Business
Annual Trading Update
Annual Trading Update.
About this update from Victrex Plc
[{"type":"text","content":"\n RNS Number : 9858T Victrex PLC 07 October 2010 \n \n\nFor Stock Exchange release at 7.00a.m. Thursday 7 October 2010\n \nVictrex plc\n \nAnnual Trading Update\n \nThe Company announces its trading update for the year ended 30 September 2010.\n \nFull year Group sales volume amounted to approximately 2,535 tonnes, an increase of 64% over the previous year (1,547 tonnes) with a half year record of 1,364 tonnes in the second half. Sales volume for October has started strongly, continuing to reinforce the positive underlying trends in the Victrex Polymer Solutions ('VPS') business.\n \nFull year revenue for Invibio®, our biomaterial solutions business, was in line with our expectations at approximately £44.2m, an increase of 29% over the previous year (£34.2m). Underlying Invibio revenue (at constant exchange rates) was up 15% on last year.\n \nOverall, we expect Group profits for 2010 to be in line with market expectations.\n \nVictrex will announce its results for the year ended 30 September 2010 on Tuesday 7 December 2010.\n \n \nEnquiries\n \n \n\n\n\n\nVictrex plc\n\n\n\n\n\n\n\nMichael Peacock, Finance Director \n\n\n 0207 357 9477 (7 October 2010)\n\n\n\n\n\n\n\n\n\n\n\n\nMHP Communications\n\n\n\n\n\n\n\nNick Denton / Barnaby Fry / Ian Payne \n\n\n0207 357 9477\n\n\n\n\n \n \nVictrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.\n \nWith over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions division ('VPS') focuses on our transport, industrial and electronics markets and our Invibio Biomaterial Solutions division ('Invibio') focuses on providing specialist solutions for medical device manufacturers.\n \n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END TSTKKADDABDDDKK \n ","length":4850,"tagName":"div"}]